10X Genomics Inc vs Xpeng Inc - ADR — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Xpeng Inc - ADR trades at $13.35 (market cap $12.96B). The key difference: Xpeng Inc - ADR is far larger — about 2.4× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Xpeng Inc - ADR nearer its low. Which is the better fit depends on your goals.
| TXG | XPEV | |
|---|---|---|
Market Cap | $5.48B | $12.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $45.80 | $28.07 |
52-Week Low | $11.34 | $12.09 |
Enterprise Value | $5.02B | $15.07B |
Trailing returns across standard periods
Latest headlines on both assets
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →